Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization
Open Access
- 1 May 2007
- journal article
- Published by Microbiology Society in Journal of General Virology
- Vol. 88 (5), 1460-1469
- https://doi.org/10.1099/vir.0.82718-0
Abstract
Virus-like particle-based vaccines for high-risk human papillomaviruses (HPVs) appear to have great promise; however, cell culture-derived vaccines will probably be very expensive. The optimization of expression of different codon-optimized versions of the HPV-16 L1 capsid protein gene in plants has been explored by means of transient expression from a novel suite of Agrobacterium tumefaciens binary expression vectors, which allow targeting of recombinant protein to the cytoplasm, endoplasmic reticulum (ER) or chloroplasts. A gene resynthesized to reflect human codon usage expresses better than the native gene, which expresses better than a plant-optimized gene. Moreover, chloroplast localization allows significantly higher levels of accumulation of L1 protein than does cytoplasmic localization, whilst ER retention was least successful. High levels of L1 (>17 % total soluble protein) could be produced via transient expression: the protein assembled into higher-order structures visible by electron microscopy, and a concentrated extract was highly immunogenic in mice after subcutaneous injection and elicited high-titre neutralizing antibodies. Transgenic tobacco plants expressing a human codon-optimized gene linked to a chloroplast-targeting signal expressed L1 at levels up to 11 % of the total soluble protein. These are the highest levels of HPV L1 expression reported for plants: these results, and the excellent immunogenicity of the product, significantly improve the prospects of making a conventional HPV vaccine by this means.Keywords
This publication has 25 references indexed in Scilit:
- Plant-Produced Cottontail Rabbit Papillomavirus L1 Protein Protects against Tumor Challenge: a Proof-of-Concept StudyClinical and Vaccine Immunology, 2006
- Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial NeoplasiaObstetrics & Gynecology, 2006
- Expression of Human Papillomavirus Type 16 L1 Protein in Transgenic Tobacco PlantsActa Biochimica et Biophysica Sinica, 2005
- Vaccination strategies for the prevention of cervical cancerExpert Review of Anticancer Therapy, 2005
- Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trialThe Lancet, 2004
- Plant-based production of biopharmaceuticalsCurrent Opinion in Plant Biology, 2004
- Production of Human Papillomavirus Type 16 Virus-Like Particles in Transgenic PlantsJournal of Virology, 2003
- Specific Inactivation of Inhibitory Sequences in the 5′ End of the Human Papillomavirus Type 16 L1 Open Reading Frame Results in Production of High Levels of L1 Protein in Human Epithelial CellsJournal of Virology, 2002
- An Agrobacterium-mediated transient gene expression system for intact leavesPlant Science, 1997
- Transgenic PlantsCold Spring Harbor Symposia on Quantitative Biology, 1985